WHAT IS CBA-CEA, AND WHY ARE THEY DOING THIS TO US

被引:20
作者
FUCHS, VR
机构
关键词
D O I
10.1056/NEJM198010163031611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:937 / 938
页数:2
相关论文
共 11 条
  • [1] CRETIN S, 1977, HEALTH SERV RES, V12, P174
  • [2] CROSBY IK, 1980, CIRCULATION, V62, P79
  • [3] FARBER ME, 1978, N ENGL J MED, V300, P856
  • [4] Frazer James George, 1922, GOLDEN BOUGH STUDY M
  • [5] MEASURES OF CLINICAL EFFICACY - COST-EFFECTIVENESS CALCULATIONS IN DIAGNOSIS AND TREATMENT OF HYPERTENSIVE RENOVASCULAR DISEASE
    MCNEIL, BJ
    VARADY, PD
    BURROWS, BA
    ADELSTEIN, SJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (05) : 216 - 221
  • [6] Neutra R., 1977, COSTS RISKS BENEFITS, P277
  • [7] FOUNDATIONS OF COST-EFFECTIVENESS ANALYSIS FOR HEALTH AND MEDICAL PRACTICES
    WEINSTEIN, MC
    STASON, WB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (13) : 716 - 721
  • [8] COSTS AND BENEFITS OF MEDICAL RESEARCH - CASE STUDY OF POLIOMYELITIS
    WEISBROD, BA
    [J]. JOURNAL OF POLITICAL ECONOMY, 1971, 79 (03) : 527 - 544
  • [9] COST-EFFECTIVENESS OF VACCINATION AGAINST PNEUMOCOCCAL PNEUMONIA
    WILLEMS, JS
    SANDERS, CR
    RIDDIOUGH, MA
    BELL, JC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (10) : 553 - 559
  • [10] ZECKHAUSER R, 1975, BENEFIT COST POLICY